News from actinium pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jan 08, 2014, 09:40 ET

With Bone Marrow Transplants Rising, New Therapy Gives Hope to Those Over 55

 Bone marrow transplants are a $1.3 billion market and the fastest-growing hospital procedure in the U.S. They are the only potential cure for...

Dec 20, 2013, 08:35 ET

Four Things to Ask Your Doctor About Bone Marrow Transplants

Those who have leukemia, lymphoma or other blood cancer diseases might have heard about bone marrow transplant as a potential treatment. As with...

Dec 09, 2013, 16:05 ET

Actinium Pharmaceuticals to Present at the 24th Annual Oppenheimer Healthcare Conference

 Actinium Pharmaceuticals, Inc. (OTCQB: ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing  innovative targeted...

Dec 09, 2013, 07:00 ET

Actinium Pharmaceuticals Announces Clinical Advisory Board Meeting At The 2013 ASH Conference

Actinium Pharmaceuticals, Inc. (OTCQB: ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...

Dec 09, 2013, 06:00 ET

Encouraging Clinical Data From Multicenter Phase 1/2 Trial On Actinium's Actimab-A Presented At American Society Of Hematology Annual Meeting

 Actinium Pharmaceuticals, Inc. (OTCQB: ATNM.OB) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted...

Dec 05, 2013, 07:00 ET

Actinium Pharmaceuticals Presenting At The LD Micro Conference Today At 12:30 pm Pacific

Actinium Pharmaceuticals, Inc. (OTCQB: ATNM.OB) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...

Dec 03, 2013, 07:00 ET

Actinium Pharmaceuticals Announces 2013 Annual Shareholder Meeting

 Actinium Pharmaceuticals, Inc. (OTCQB: ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...

Dec 03, 2013, 07:00 ET

Actinium Pharmaceutical's Announces Analyst Coverage

BURTON, Mich., Dec. 3, 2013 /PRNewswire/-- Actinium Pharmaceuticals, Inc. (OTCQB: ATNM) a pharmaceutical company developing drugs for...

Dec 02, 2013, 07:00 ET

Actinium Pharmaceuticals Announces Additional Clinical Data From Multicenter Phase 1/2 Trial on Actinium's Actimab-A to Be Presented at American Society of Hematology Annual Meeting

Actinium Pharmaceuticals, Inc. (OTCQB: ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...

Nov 21, 2013, 07:00 ET

Actinium Pharmaceuticals To Present At The LD Micro Conference

 Actinium Pharmaceuticals, Inc. (OTCQB: ATNM.OB) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted...

Nov 18, 2013, 07:00 ET

Actinium Pharmaceuticals Announces Plans For Iomab™-B Phase 3 Pivotal Trial Following Meeting With FDA

 Actinium Pharmaceuticals, Inc. (OTCQB: ATNM.OB) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative, targeted...

Nov 12, 2013, 07:00 ET

Actinium Pharmaceuticals Appoints Richard Steinhart As New Independent Director

Actinium Pharmaceuticals, Inc. (OTCQB: ATNM.OB) ("Actinium" or "the Company"), a biopharmaceutical Company developing  innovative targeted...

Nov 08, 2013, 07:00 ET

Actinium Pharmaceuticals To Host Corporate Update And Virtual Roadshow Conference Call On November 11

Actinium Pharmaceuticals, Inc. (OTCQB: ATNM.OB) ("Actinium" or "the Company"), a biopharmaceutical Company developing  innovative targeted...

Oct 31, 2013, 06:30 ET

Actinium Pharmaceuticals to Host Corporate Update and Virtual Roadshow Conference Call on November 11

Actinium Pharmaceuticals, Inc. (OTCQB: ATNM.OB) ("Actinium" or "the Company"), a biopharmaceutical Company developing  innovative targeted...

Oct 15, 2013, 07:00 ET

Actinium Pharmaceuticals Webinar To Discuss Iomab™-B At 11AM EDT Today

 Actinium Pharmaceuticals, Inc. (OTCQB: ATNM.OB) ("Actinium" or "the Company"), a biopharmaceutical Company developing  innovative...

Oct 03, 2013, 16:04 ET

Actinium Pharmaceuticals Announces Upcoming Webinar To Discuss Iomab™-B

 Actinium Pharmaceuticals, Inc. (OTCQB: ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing  innovative...

Sep 18, 2013, 06:00 ET

Actinium Pharmaceuticals Appoints Corey Sohmer As Vice President Of Finance And Business Development

 Actinium Pharmaceuticals, Inc. (OTCQB: ATNM.OB) ("Actinium" or "the Company"), a biopharmaceutical Company developing  innovative...

Sep 16, 2013, 06:00 ET

Actinium Pharmaceuticals Appoints Kaushik J. Dave, Ph.D., MBA As President, Chief Executive Officer And Director

 Actinium Pharmaceuticals, Inc. (OTCQB: ATNM.OB) ("Actinium" or "the Company"), a biopharmaceutical Company developing  innovative...

Jul 09, 2013, 07:00 ET

Actinium Pharmaceuticals Clinical Results Featured at a United Nations Forum

 Actinium Pharmaceuticals Inc. (OTCQB: ATNM), a biopharmaceutical company that develops innovative targeted payload immunotherapeutics for...

Jun 07, 2013, 07:00 ET

Actinium Pharmaceuticals, Inc. Receives $3.5m from Exercise of Warrants

 Actinium Pharmaceuticals, Inc. (OTCQB: ATNM) announced today the recent issuance of 2,095,204 of its shares of common stock pursuant to the...